Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimising homeostasis.

P M Bath1

  • 1Division of Stroke Medicine, University of Nottingham, City Hospital Campus, UK.

British Medical Bulletin
|November 25, 2000
PubMed
Summary
This summary is machine-generated.

Stroke patients with high blood pressure, high blood sugar, high body temperature, and high intracranial pressure face poor prognoses. However, randomized controlled trials are lacking for managing these common stroke complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Key design elements of successful acute ischemic stroke treatment trials.

Neurological research and practice·2023
Same author

The Landscape of Videofluoroscopy in the UK: A Web-Based Survey.

Dysphagia·2020
Same author

No Association Between Serum Platelet-derived Growth Factor, Platelet Size, and Regression of Angiographically-defined Coronary Artery Disease.

Platelets·2010
Same author

Platelet and Erythrocyte Volume and Count: Epidemiological Predictors of Impedance Measured ADP-Induced Platelet Aggregation in Whole Blood.

Platelets·2010
Same author

Original articles: increased platelet volume in patients with adult polycystic kidney disease.

Platelets·2010
Same author

Von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke sub-type and functional outcome.

Platelets·2006
Same journal

Augmentation in Achilles tendon repair: evidence versus enthusiasm.

British medical bulletin·2026
Same journal

Regional musculoskeletal pain in workers-is the traditional medical model increasing disability?

British medical bulletin·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
See all related articles

Area of Science:

  • Neurology
  • Critical Care Medicine
  • Clinical Trials

Background:

  • Hypertension, hyperglycemia, hyperthermia, and intracranial hypertension are independent predictors of poor outcomes post-stroke.
  • These conditions are frequently observed in stroke patients, yet evidence-based management guidelines are scarce.

Purpose of the Study:

  • To highlight the critical need for randomized controlled trials (RCTs) to guide the management of common post-stroke complications.
  • To emphasize the lack of evidence for managing these conditions despite their prognostic significance.

Main Methods:

  • Review of existing experimental and clinical data regarding post-stroke complications.
  • Analysis of the current evidence base, specifically the absence of RCTs for managing hypertension, hyperglycemia, hyperthermia, and intracranial hypertension.

Related Experiment Videos

Main Results:

  • Significant experimental and clinical data link these conditions to poor stroke prognosis.
  • A striking deficiency of evidence from randomized controlled trials exists for their management.
  • Non-patented treatments necessitate government or charity funding for RCTs.

Conclusions:

  • Urgent need for academic researchers to design and conduct robust RCTs for post-stroke complications.
  • In the absence of RCT data, treat severe hyperglycemia and pyrexia; generally avoid treating acute hypertension unless severe or complicated.
  • Cerebral edema management remains a significant clinical enigma requiring further research.